Login / Signup

Letter: anti-TNF dose de-escalation in Crohn's disease-a case-by-case decision.

Nicola ImperatoreA TestaN CaporasoA Rispo
Published in: Alimentary pharmacology & therapeutics (2017)
Keyphrases
  • rheumatoid arthritis
  • open label
  • decision making
  • clinical trial
  • randomized controlled trial